×
Back to Agenda
Session 8: Hot Topics
Session Chair(s)
Emily Place, PHD, MPH
Senior Consultant, Aclairo Pharmaceutical Development Group, United States
Ronald Wange, PHD
Principal Consultant, Aclairo Pharmaceutical Development Group, Inc., United States
Session 8: Hot Topics
Speaker(s)
Robert Bell, PHD
CSO, Ascidian, United States
Presentation Title: Harnessing RNA Exon Editing to Rewrite the Underlying Causes of Genetic Diseases
Stefan Lutz, PHD
Chief Scientific Officer, Codexis, Inc. , United States
siRNA Manufacturing with Engineered Enzymes
Ronald Wange, PHD
Principal Consultant, Aclairo Pharmaceutical Development Group, Inc., United States
Confusion Arising from a Shared Vocabulary: What does “Platform” Really Mean?
Have an account?